This site is intended for healthcare professionals only
LoginRegister
Submit rationality and desirability of Rizatriptan plus Naproxen: CDSCO Panel Tells Akum Drugs and PharmaceuticalSubmit rationality and desirability of Rizatriptan plus Naproxen: CDSCO Panel Tells Akum Drugs and...
Trademark Win for Mankind: HC Rejects FLORASIS Over Similarity with FLORATrademark Win for Mankind: HC Rejects FLORASIS Over Similarity with FLORA
Novartis Healthcare Gets CDSCO Panel Nod To study Anti-cancer Drug AsciminibNovartis Healthcare Gets CDSCO Panel Nod To study Anti-cancer Drug Asciminib
MediBuddy ropes in Sidhartha Mehra as CFOMediBuddy ropes in Sidhartha Mehra as CFO
Cybersecurity incident at Alkem Labs US arm, investigation underwayCybersecurity incident at Alkem Labs US arm, investigation underway
Biocon Pharma gets USFDA nod for deep vein thrombosis drug RivaroxabanBiocon Pharma gets USFDA nod for deep vein thrombosis drug Rivaroxaban
Former Coca-Cola executive Punita Lal joins Lupin Board as Additional DirectorFormer Coca-Cola executive Punita Lal joins Lupin Board as Additional Director
Lupin Rivaroxaban Tablets approved by USFDALupin Rivaroxaban Tablets approved by USFDA
Alembic Pharma appoints Jigr Shah as Head - Business FinanceAlembic Pharma appoints Jigr Shah as Head - Business Finance
DTAB Agrees to Prohibit 16 FDCs Identified as IrrationalDTAB Agrees to Prohibit 16 FDCs Identified as Irrational
CDSCO Panel Demands Structured Phase IV Protocol for Ademetionine in Liver Disease SubtypesCDSCO Panel Demands Structured Phase IV Protocol for Ademetionine in Liver Disease Subtypes
Trademark Win for Mankind: HC Rejects FLORASIS Over Similarity with FLORAMankind Pharma hit with over Rs 341 crore additional tax demand from IT authority
X